CJC-1295 (No DAC) Supplier Comparison: What Separates Real Labs

Pharmacological Profile and Mechanism of Action

CJC-1295 (No DAC)—also designated in literature as Modified GRF (1-29)—is a synthetic 29-amino-acid peptide analog of naturally occurring Growth Hormone-Releasing Hormone (GHRH). By substituting specific amino acids at positions 2, 8, 15, and 27 (typically D-Ala, Gln, Ala, and Leu respectively), the molecule exhibits increased enzymatic stability against dipeptidyl peptidase-4 (DPP-IV) cleavage while retaining high binding affinity for the GHRH receptor.

In preclinical models, CJC-1295 (No DAC) functions as a selective GHRH analog. Studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research, it serves as an essential tool for evaluating somatotroph signaling kinetics. Preclinical studies suggest that stimulation of the GHRH receptor triggers signal transduction via the cAMP/protein kinase A (PKA) pathway, causing a physiological, pulsatile release of endogenous growth hormone without disrupting basal feedback regulation.

Comparative Analysis of Growth Hormone Secretagogues

When designing protocols to investigate the somatotropic axis, researchers frequently compare GHRH analogs with growth hormone secretagogue receptor (GHSR-1a) agonists to establish signaling differences. For instance, pairing a GHRH peptide like CJC-1295 (No DAC) with a selective ghrelin receptor agonist like Ipamorelin demonstrates synergistic GH release in animal models compared to either compound administered in isolation.

To select the appropriate secretagogue for specific in vitro or in vivo endpoints, laboratories must consider chemical modifications, receptor selectivity, and biological half-life. The following matrix illustrates structural and pharmacological distinctions across related compounds in our catalog of research peptides:

• CJC-1295 (No DAC): Selective GHRH receptor agonist; modified 29-amino-acid sequence; short systemic half-life (~30 minutes) mimicking endogenous GHRH pulses. • CJC-1295 with DAC: GHRH receptor agonist conjugated to a Drug Affinity Complex; covalent binding to serum albumin extends half-life to several days, altering natural pulsatility. • Sermorelin: Unmodified truncated GHRH (1-29) sequence; rapid enzymatic clearance, highly sensitive to DPP-IV degradation in biological matrix assays.

Risks of Subpar Materials in Quantitative Laboratory Research

Using unverified or poorly synthesized peptides in experimental models introduces significant confounding variables that can invalidate empirical data. Impurities such as truncated peptide sequences, residual coupling reagents, organic solvents, and trifluoroacetic acid (TFA) salts can exert cellular toxicity or interfere with receptor binding kinetics.

In cell culture models, high levels of bacterial endotoxins or unreacted synthetic side-products induce non-specific inflammatory signaling pathways, altering gene expression profiles independently of GHRH receptor activation. For quantitative assays measuring IGF-1 transcription, collagen synthesis, or cellular proliferation, batch variability across unvetted suppliers degrades statistically significant results.

Technical Supplier Evaluation Rubric: Core Laboratory Standards

To establish a standardized procurement standard, research institutions should evaluate suppliers across five non-negotiable operational domains: analytical testing transparency, facility compliance, manufacturing origin, endotoxin control, and lot-level traceability.

An objective evaluation protocol begins with verifying that every batch undergoes independent analysis. Vendors must provide a accessible, public lot-specific COA verification portal containing raw High-Performance Liquid Chromatography (HPLC) chromatograms and Mass Spectrometry (MS) spectra rather than simple summary statements or non-traceable documents.

Evaluating Quality Documentation: HPLC and Mass Spectrometry

A valid Certificate of Analysis for CJC-1295 (No DAC) must include both Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS) data. RP-HPLC confirms chromatographic purity by quantifying the peak area integration of the target peptide relative to synthesis impurities.

Mass Spectrometry establishes precise molecular weight identity. For CJC-1295 (No DAC) (molecular formula C152H252N44O42, theoretical monoisotopic mass ~3367.9 Da), MS analysis confirms correct amino acid assembly and rules out incorrect deletion sequences or incomplete deprotection. Quality vendors ensure chromatographic purity consistently exceeds 98% with target mass match within ±1 Da.

Endotoxin Control and Bioburden Testing Parameters

Endotoxins (lipopolysaccharides derived from the outer membrane of Gram-negative bacteria) present severe risks to cell culture viability and biological assays. In vitro data indicate that endotoxin exposure downregulates specific receptor targets and triggers unexpected cytokine release.

Strict procurement standards require quantitative Limulus Amebocyte Lysate (LAL) testing for every production batch. High-tier suppliers enforce endotoxin limits below 0.1 EU/mg, verifying suitability for sensitive cell lines, tissue explants, and animal model research protocols.

USA Manufacturing Standards and Synthesis Precision

The chemical synthesis of CJC-1295 (No DAC) requires Solid-Phase Peptide Synthesis (SPPS) using Fmoc chemistry, followed by resin cleavage, peptide purification via preparative HPLC, and controlled lyophilization. Domestic manufacturing in cGMP-compliant facilities under ISO 9001 and ISO 17025 accreditation ensures strict adherence to atmospheric humidity controls, temperature monitoring, and solvent purification.

Lyophilization processes must result in a stable, uniform cake structure with low residual moisture content (typically <3%). Excess water accelerates peptide hydrolysis and aggregation during storage, degrading compound integrity prior to experimental reconstitution.

In-Lab Handling, Reconstitution, and Storage Protocols

Proper handling procedures are required to maintain peptide integrity following receipt. Lyophilized CJC-1295 (No DAC) should be stored at -20°C or -80°C for long-term stability, protected from ambient light and thermal fluctuations.

Reconstitution should be conducted inside a laminar flow hood using sterile bacteriostatic water or target-appropriate buffer solutions. Researchers can calculate exact molar concentrations and liquid delivery volumes using our free lab reconstitution calculator. Avoid vigorous vortexing, as mechanical shear stress can disrupt secondary structure; gentle swiriling is recommended to achieve complete dissolution.

Procurement Protocol and Institutional Support Framework

Institutional buyers require efficient supply chains, transparent lot tracking, and robust customer support to align with strict project timelines. Suppliers supporting high-throughput laboratories must maintain transparent inventory, provide SDS documentation, and offer dedicated support for technical inquiries.

PX1 Research maintains a fully integrated domestic supply chain with direct fulfillment from facilities in California and Arizona. Orders placed Monday through Friday ship same-day, ensuring fast delivery for critical research projects. Laboratories requiring bulk quantities or dedicated procurement terms can access specialized options via our institutional wholesale account portal or explore our broader peptide research hub.

Objective Scoring Framework Matrix for Laboratory Supplier Selection

To facilitate vendor evaluation, procurement managers can utilize the weighted scoring rubric detailed below. This matrix assigns quantitative scores across key performance factors to differentiate high-tier research suppliers from unverified vendors:

1. Analytical Testing (Weight: 30%): Requirement: Lot-specific HPLC and LC-MS from an accredited ISO 17025 laboratory. High Standard: Complete raw chromatograms provided. Low Standard: Generic or missing analytical reports. 2. Endotoxin Verification (Weight: 20%): Requirement: LAL testing report per lot. High Standard: < 0.1 EU/mg confirmed. Low Standard: No endotoxin testing performed. 3. Manufacturing Integrity (Weight: 20%): Requirement: USA-manufactured in GMP-compliant facilities. High Standard: Fully traceable batch records. Low Standard: Unknown or offshore manufacturing origin. 4. Storage & Stability Standards (Weight: 15%): Requirement: Cold-chain storage, vacuum-sealed lyophilization. High Standard: < 3% residual moisture. Low Standard: Variable moisture content, degraded cake. 5. Logistics & Support (Weight: 15%): Requirement: Dedicated lab support, direct same-day fulfillment. High Standard: Same-day shipping from CA/AZ, complete SDS. Low Standard: Delayed shipping, no phone/technical support.